Figure1 (Deferasirox Fig1)
Deferasirox Granule
Product Images NDC 59651-447
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 59651-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Deferasirox-fig2.jpg (Deferasirox Fig2)
Deferasirox-fig3.jpg (Deferasirox Fig3)
This is a medication label for Deferasirox Oral Granules in a child-resistant unit dose package. The granules come in 30 sachets, each containing 138.5 mg granules equivalent to 1090 mg deferasirox. Instructions for usage include shaking the sachet gently, tearing it open along a line, and pouring the contents into soft food to be immediately consumed. The pharmacist is advised to dispense the Medication Guide separately to each patient. The dosage information is available in the prescribing information, and the product should be stored at 20° to 25°C (68° to 77°F) in a controlled room temperature to protect from moisture. The package is child-resistant, and all drugs should be kept out of the reach of children. Additionally, the product is distributed by Aurobindo Pharma USA, Inc., and made in India.*
Deferasirox-fig4.jpg (Deferasirox Fig4)
Deferasirox-fig5.jpg (Deferasirox Fig5)
Deferasirox-fig6.jpg (Deferasirox Fig6)
Deferasirox-fig7.jpg (Deferasirox Fig7)
Str (Deferasirox Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
